APOA1 and metabolic dysfunction-associated steatotic liver disease: Compared to the control, both NR1H4 and APOA1 expression were down-regulated in the NAFLD group, YCHT M and YCHT H treatment significantly increased the NR1H4 and APOA1 protein levels of NAFLD mice (Fig. 9A–B).